SAB Biotherapeutics, Inc. (SABS) Earnings Call Transcripts
About SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. (SABS) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 3 calls on record spanning May 12, 2026 to September 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 3 SAB Biotherapeutics, Inc. earnings call transcripts on record, spanning May 12, 2026 to September 10, 2026. Based on this history, SAB Biotherapeutics, Inc. reports quarterly. The most recent call on file is dated September 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- SABS
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Biotechnology
- Calls on record
- 3
- First call
- May 12, 2026
- Most recent
- September 10, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Company Conference Presentations | Sep 10, 2026 | Read transcript → |
| Q2 FY2026 | Aug 6, 2026 | Read transcript → |
| Q1 FY2026 | May 12, 2026 | Read transcript → |